Nymox Pharmaceutical (NYMXF) Research & Development (2017 - 2024)
Nymox Pharmaceutical's Research & Development was $1.48 million in FY2025, down 54.8% from $3.28 million in FY2024.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Research & Development (2017 - 2024) Analysis & Trends
From FY2015 onward, Nymox Pharmaceutical has reported Research & Development for 11 years.
- Research & Development shows a five-year compound annual growth rate of -28.8% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Research & Development in data going back to FY2015.
- Per Business Quant data, Research & Development in earlier years was $3.28 million in FY2024 (-17.9%), $3.99 million in FY2023 (+5.9%), $3.77 million in FY2022 (-43.3%) and $6.66 million in FY2021 (-18.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 624,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 661,000.00 |
| Jun 30, 2023 | 594,000.00 |
| Mar 31, 2023 | 720,000.00 |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 892,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 1.43 Mn |
| Dec 31, 2020 | 1.17 Mn |
| Sep 30, 2020 | 3.24 Mn |
| Jun 30, 2020 | 2.16 Mn |
| Mar 31, 2020 | 1.56 Mn |
| Dec 31, 2019 | 1.80 Mn |
| Sep 30, 2019 | 1.51 Mn |
API Access
Nymox Pharmaceutical Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();